Abstract Background Immune checkpoint inhibitor therapy can elicit deep and durable immune responses in patients with cancer, although most do not experience long-term remission. Tumor hypoxia contributes to this treatment failure. We tested whether the clinical-stage hypoxia-activated prodrug tarloxotinib enhances imm...
Zhe Fu, V. Jackson-Patel, K. Farrand et al.· Journal for ImmunoTherapy of...· 0 citations
Malic enzymes (ME) regulate central carbon metabolism and cellular redox balance, and the mitochondrial isoform ME2 is frequently upregulated in aggressive cancers to support metabolic flexibility and stress resistance. Isoform‐selective inhibition has remained out of reach because the catalytic machinery is essentiall...
Ben A. Krinkel, Y. Yosaatmadja, M. Slayton et al.· Protein Science· 0 citations
Overall, this study identifies MIH-36 as a promising lead compound with a multifaceted anticancer activity profile, associated with reduced proliferation, migration, and survival of breast cancer cells, potentially through modulation of VEGFR-2-associated pathways.
Guzide Satir-Basaran, Ahmed Amleh, Antonio Curcio et al.· Bioorganic chemistry (Print)· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.